Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors

AJ Gelderblom, R Salazar, Jaap Verweij, G Pentheroudakis, Maja de Jonge, M Devlin, CMC Hooije, F Seguy, R Obach, J Prunonosa, P Principe, C Twelves

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Scopus)
1 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)4101-4107
Number of pages7
JournalClinical Cancer Research
Volume9
Publication statusPublished - 2003

Cite this